Argentus Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-11,537
| Closed | -$531K | – | 499 |
|
|
2016
Q3 | $531K | Buy |
11,537
+5,427
| +89% | +$250K | 0.19% | 126 |
|
|
2016
Q2 | $307K | Buy |
6,110
+3,408
| +126% | +$171K | 0.13% | 236 |
|
|
2016
Q1 | $145K | Buy |
2,702
+579
| +27% | +$31.1K | 0.05% | 354 |
|
|
2015
Q4 | $139K | Sell |
2,123
-41,719
| -95% | -$2.73M | 0.04% | 318 |
|
|
2015
Q3 | $2.48M | Buy |
43,842
+670
| +2% | +$37.8K | 0.37% | 67 |
|
|
2015
Q2 | $2.55M | Buy |
43,172
+1,731
| +4% | +$102K | 0.39% | 69 |
|
|
2015
Q1 | $2.58M | Buy |
41,441
+1,416
| +4% | +$88.2K | 0.41% | 64 |
|
|
2014
Q4 | $2.3M | Sell |
40,025
-976
| -2% | -$56.1K | 0.39% | 75 |
|
|
2014
Q3 | $2.2M | Buy |
41,001
+94
| +0.2% | +$5.05K | 0.35% | 75 |
|
|
2014
Q2 | $2.14M | Sell |
40,907
-1,357
| -3% | -$71.1K | 0.56% | 36 |
|
|
2014
Q1 | $2.23M | Buy |
42,264
+2,187
| +5% | +$116K | 0.54% | 30 |
|
|
2013
Q4 | $1.61M | Buy |
40,077
+1,108
| +3% | +$44.4K | 0.34% | 47 |
|
|
2013
Q3 | $1.47M | Buy |
38,969
+2,728
| +8% | +$103K | 0.34% | 49 |
|
|
2013
Q2 | $1.42M | Buy |
+36,241
| New | +$1.42M | 0.34% | 59 |
|